Helus Share Price
NASDAQ: HELP | OthersHelus Stock Performance
Helus Share Price Today
As of 19 November 2026, Helus Pharma Inc.'s share price is $6.88. The stock opened at $7.06, compared to its previous close of $7.17. During today's trading session, Helus Pharma Inc.'s share price traded between $6.70 and $7.40, with an average price of $7.05. Over the past 52 weeks, the stock has recorded a high of $14.88 and a low of $3.78. In terms of performance, Helus Pharma Inc.'s share price has risen by 51.38% over the last six months and is up 4.08% on a year-on-year basis.
Helus Share Price Chart
About Helus
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
Helus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.85 | $6.88 | -35.08% |
Oct 2026 | $12.38 | $10.59 | -13.80% |
Sep 2026 | $11.79 | $12.29 | -7.11% |
Aug 2026 | $7.88 | $13.22 | +69.33% |
Jul 2026 | $6.49 | $7.81 | +18.33% |
Jun 2026 | $4.42 | $6.60 | +45.21% |
May 2026 | $5.26 | $4.54 | -14.25% |
Apr 2026 | $4.94 | $5.30 | +10.65% |
Mar 2026 | $7.13 | $4.79 | -34.79% |
Feb 2026 | $6.51 | $7.34 | +11.12% |
Jan 2026 | $8.60 | $6.61 | N/A |